Skip to main content

Schedule

The LDN Research Trust is proud to offer presentations introducing virtually all a practitioner would need to know about the effective use of LDN. For more extensive information on the use of LDN, be sure to register for a Full Ticket or Livestream so that you can also access our additional recorded sessions. 

2019 Schedule

8.00am

Exhibition Opens

Visit the Exhibitors

8.30am

Registration

The LDN Team

9.00am

MC

Mark Mandel, Pharm D

9.05am

Welcome

Linda Elsegood

9.10am

Mechanism of Action

Stephen Dickson BSC (hons) MRPharmS

9.50am

Cancer

Prof Angus Dalgleish, MD

10.10am

Cancer - Case Studies

Akbar Khan, MD

10.50am

20 Minute

Break

11.10am

11.30am

MS and Research

Tony Turel, MD

11.50am

Q&A Panel

Submit your questions to questions@ldn2019.com

12.50pm

2.50pm

Major Depressive Disorder

Beth Livengood NMD

2.30pm

Traumatic Brain Injury

Jordan Atkinson, ND

2.50pm

Mental Health

Galyn Forster, MS

3.10pm

PTSD/Dissociative Disorder

Ulrich Lanius, PhD

3.10pm

20 Minute

Break

3.50pm

Clinical Case Studies

Jill Cottel, MD

4.10pm

Endometriosis

Olga Cortez, MD

4.30pm

Q&A Panel

Submit your questions to questions@ldn2019.com

5.30pm

Poster Presentations

Competition

6.30pm

Networking Party

Your chance to network with the speakers and attendees

8.00pm

Networking Party and

Exhibition Closes

8.00am

Exhibition Opens

The LDN Team

8.30am

Registration

The LDN Team

9.00am

MC

Mark Mandel, Pharm D

9.05am

Welcome

Linda Elsegood

9.30am

LDN and Pain

Samyadev Datta, MD

9.50am

Fibromyalgia

Ginevra Liptan MD

10.10am

LDN and treatment resistant pain

Yoon Hang "John" Kim, MD

10.30am

10.50am

20 Minute

Break

11.10am

Pots

Leonard Weinstock, MD

11.30am

ME/CFS

Kent Holtorf, M.D

11.50 am

Q&A Panel

Submit your questions to questions@ldn2019.com

12.50pm

1.50pm

LDN and Parkinson's

Ted Cole, DO

2.30pm

LDN and Memory Loss

Pamela Smith, MD

2.50pm

Sleep

Elissa Mullen ND

3.10pm

Gutsy research:Latest findings on how to improve gut health

Jill Brook MA

The research is pouring in fast about how diet and lifestyle can impact gut health, and how gut health affects all health.This presentation will share the latest studies that can help guide practical strategies, such as new findings about foods, supplements, various forms of fasting, and other habits.As always, Jill will focus on how patients can make the most progress with the least amount of deprivation and willpower, so that new healthy habits are maintainable long-term

3.30pm

3.50pm

Pediatric's and LDN

Paul Anderson, NMD

4.10pm

Children

Brian Udell MD

4.10pm

Q&A Panel

Submit your questions to questions@ldn2019.com

5.30pm - 6.30pm

Visit the

Exhibitors

8.00am

Exhibition Opens

The LDN Team

8.30am

Registration

The LDN Team

9.00am

MC

Mark Mandel, Pharm D

9.05am

Welcome

Linda Elsegood

9.10am

Graves' Disease

Sarah Zielsdorf, MD, MS

9.30am

Hashimoto's

Kent Holtorf, M.D

9.50am

LDN and Cellular Hypothyroidism: When TSH is Normal but Reverse T3 is Elevated

Carrie Jones, ND, MPH

Hypothyroidism is well understood in conventional medicine as an elevated TSH along with associated symptoms. Unfortunately, TSH is determine by the levels of T3 in the pituitary as determined by the type 2 deiodinase. In the periphery, type 1 deiodinase is what converts T4 into T3 while type 3 deiodinase converts T4 into reverse T3. Understanding what might cause a decrease in either type 1 or type 2 or an increase in type 3 deiodinase coupled with low dose naltrexone treatment could greatly improve lab and symptom outcomes in patients with hypothyroidism or for those who experience classical hypothyroid symptoms but have a TSH within range on a lab report.

10.10am

10.30am

Gut and Thyroid Connection

Michael Ruscio, MD

10.50am

20 Minute

Break

11.10am

Mast Cell Activation Syndrome

Leonard Weinstock, MD

11.30am

Crohn's Case Studies

Paul Battle, PA-C

11.50am

Pets

Mark Mandel, Pharm D

12.10am

Q&A Panel

Submit your questions to questions@ldn2019.com

1.10pm

Round Up

Mark Mandel, Pharm D

1.15pm - 2.00pm

Visit the

Exhibitors

LDN and Pain

Andrew David Shiller MD

Compounding 101: The Basics of Compounding with Naltrexone

Tara Thompson, PharmD

There is much more to compounding pharmacy than mixing ingredients. This presentation will give a glimpse into the world of compounding pharmacy, the regulations and guidelines that we strive to meet, how to choose a compounding pharmacy, and how to writefor a low dose naltrexone compounded prescription. Specifically, different bases and equipment used in the compounding of low dose naltrexone will be discussed and how to choose the right dosage form for your unique patient. 

Case Studies from a Women's Health Naturopathic Practice

Tracy Magerus

Many general practitioners may feel intimidated to include LDN into their regular patient care.Dr. Mageruswill present 6 cases from her practice where she has successfully used LDN as an adjunctive therapy to treat infertility, lupus, endometriosis, multiple sclerosis and hashimoto's thyroiditis.

Mast Cell Activation Syndrome (MCAS): When Histamine Goes Haywire

Jill Carnahan MD

Mast cells are present in most tissues throughout the human body, especially connective tissue, skin, intestinal lining cardiovascular system, nervous system, and reproductive organs. They are part of the allergic response designed to protect us from threat and injury.When the body is exposed to a perceived threat, the mast cells secrete chemical mediators, such as histamine,interleukins, prostaglandins, cytokines, chemokine and various other chemicalsstored in the cytoplasm of the cell. These chemicalmessengers produce both local and systemic effects, such as increased permeability of blood vessels (inflammation and swelling), contraction of smooth muscle (stomach cramps and heart palpitations), and increase mucous production (congestion, sneezing, etc). Historically, we thought of mast cells only in relation to an allergic or anaphylactic response. We now know they play a profound role in immune activation, development of autoimmunity and many other disorders, such as POTS (postural orthostatic tachycardia syndrome). Sadly we are seeing a large increase in patients presenting with mast cell disorders and MCAS. I believe it is in part dueto the onslaught of more pervasiveenvironmental toxins, molds and chemicals.

Telemedicine

Sajad Zalzala, MD

Client Attraction Secrets: Become a Sought After Expert With a Full Practice of Ideal, Committed Clients (Regardless of Insurance

Lesli Bitel

  • Where to focus your marketing muscle that will skyrocket your inquiries...even thoughit seems counter-intuitive
  • 4 biggest mistakes wellness professionals make in describing their work that actually pushes clients away...and what to do instead
  • The fastest ways to get in front of ideal clients, both locally and online-How to move out of trading “hours for dollars” into a more effective (and lucrative) business model -even if you take insurance!
  • The top business practice for building your thriving practice... it’s likely not what you think!

LDN and vulvodynia

Debbie Rice ND

A Pharmacist's Perspective on Comprehensive Immune Health Consultations and Applications of LDN

Amy Lamb Pharm

This session will review the interactions and assessments in a community pharmacy practice that result in recommendations for LDN therapy initiation. The session will also review complementary therapies for patients seeking functional improvement of immune dysregulation

Using Low Dose Naltrexone To Help SIBO Patients

Mona Morstein ND

SIBO, small intestine bacterial overgrowth, is estimated to account for up to 60% of all IBS patients.  That’s millions of patients.  The core etiology of developing SIBO is due to auto-immune damage to the nerves that stimulate the muscles of the small gut to move contents forward.  As a result, the colon backwashes bacteria/archae into the small gut and they proliferate, causing significant symptoms and damage to the small gut lining.   Low Dose Naltrexone can be an invaluable tool in working with SIBO patients.  It can help reduce the auto-immunity and acts as a gentle prokinetic, helping to move contents forward to prevent SIBO recurrence.  Learn about SIBO, auto-immunity, prokinetics at this interesting lecture by a SIBO expert." 

The Use of LDN to treat Connective Tissue Diseases

Scott Zashin MD

This talk with focus on two common connective tissue diseases, Sjogren's Syndromeand Systemic Lupus. There will be a review of both diseases in terms of diagnosis and treatment. In addition, informative case reports will be presented where LDN has been beneficial after standard therapy was not useful. In addition, there will be a brief discussion of why LDN may be an effective treatmentfor both controlling inflammation and disease symptoms.